Abstract | Objective: Methods: We measured the proliferation of SCC-9 cells in a control group, an FGF3 intervention group, and a fibroblast growth factor (FGFR) inhibitor intervention group in cholecystokinin octapeptide (CCK-8) experiments. We studied effects of FGF3 on the cell cycle and apoptosis of tongue cancer cells using flow cytometry. We further explored the IRS1/PI3K/AKT signaling pathway by measuring BCL-2 and Bcl-2 Associated X- protein (BAX) mRNA and protein levels with RT-PCR and western blot, respectively. Results: Results from the CCK-8 experiment showed that survival rates of cells in the control group, FGF3 intervention group, and FGFR inhibitor intervention group were 100.000% ± 4.026%, 136.330% ± 9.779%, and 83.199% ± 4.954%, respectively; survival rates of SCC-9 cells in all three groups were statistically significant (P < 0.05). Compared with that in the control group, the ratio of cells in G0/G1 phase in the FGFR inhibitor intervention group was higher (P < 0.05) and that in G2/M phase was lower, while the FGF3 intervention group showed opposite results (P < 0.05). The apoptosis rate of tongue cancer cells differed significantly between the FGFR inhibitor intervention and the control groups (P < 0.05). The mRNA and protein expression levels of IRS1, PI3K, and BCL-2 were all increased in the FGF3 intervention group (P < 0.05), while BAX mRNA and protein expression levels were decreased (P < 0.05). The mRNA expression levels of protein kinase B (AKT) showed no differences between groups. The p-AKT protein was overexpressed, while the total amount of AKT protein remained stable (P < 0.05). Conclusion: FGF3 contributes to the proliferation of SCC-9 cells by increasing the proportion of cells in G2/M phase. Therefore, appropriately timed inhibition of FGF3 can potentially promote tumor apoptosis through the IRS1/PI3K/AKT signaling pathway. Our results demonstrate the role of FGF3 in the tumor microenvironment in tongue squamous cell carcinoma SCC-9 cells and suggest new therapeutic targets.
|
Authors | Yang Zhang, Pan Liu, Weipeng Su, Gaowa Aodeng, Huarong Zhao |
Journal | Computational and mathematical methods in medicine
(Comput Math Methods Med)
Vol. 2022
Pg. 3331119
( 2022)
ISSN: 1748-6718 [Electronic] United States |
PMID | 35720042
(Publication Type: Journal Article, Retracted Publication)
|
Copyright | Copyright © 2022 Yang Zhang et al. |
Chemical References |
- FGF3 protein, human
- Fibroblast Growth Factor 3
- Proto-Oncogene Proteins c-bcl-2
- RNA, Messenger
- bcl-2-Associated X Protein
- Proto-Oncogene Proteins c-akt
- Sincalide
|
Topics |
- Apoptosis
(genetics)
- Carcinoma, Squamous Cell
(metabolism)
- Cell Line, Tumor
- Cell Proliferation
(genetics)
- Fibroblast Growth Factor 3
(pharmacology)
- Humans
- Phosphatidylinositol 3-Kinases
(metabolism)
- Proto-Oncogene Proteins c-akt
(metabolism)
- Proto-Oncogene Proteins c-bcl-2
(genetics, pharmacology, therapeutic use)
- RNA, Messenger
(genetics)
- Sincalide
(pharmacology, therapeutic use)
- Tongue
- Tongue Neoplasms
(drug therapy, genetics, pathology)
- Tumor Microenvironment
- bcl-2-Associated X Protein
(pharmacology)
|